stella
beta
China Post-approval Commitment (PAC) Study of Avalglucosidase Alfa in Participants With IOPD — Stella
Recruiting
Back to Glycogen Storage Disease Type II trials
Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations
(1 site)
China
Investigational Site Number: 1560001, Shanghai
View full record on ClinicalTrials.gov